Trials / Conditions / Diffuse Scleroderma
Diffuse Scleroderma
4 registered clinical trials studyying Diffuse Scleroderma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients NCT04837131 | Michael M. Pham | Phase 2 |
| Completed | A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Sc NCT01881529 | Gilead Sciences | — |
| Unknown | IVIG Treatment in Systemic Sclerosis NCT01785056 | Georgetown University | N/A |
| Completed | IL1-TRAP, Rilonacept, in Systemic Sclerosis NCT01538719 | Boston University | Phase 1 / Phase 2 |